Ursa Analytics Inc

Ursa Analytics Inc., based in Denver, CO, is at the forefront of developing innovative diagnostic solutions for sepsis, a severe condition caused by infections that affects millions globally. Their patented approach combines flow imaging microscopy with deep learning techniques to rapidly detect and identify pathogens from blood samples, significantly reducing the time required for diagnosis.

The company's technology aims to address the limitations of traditional blood culture methods, which can take up to 48 hours and often yield false negatives. By optimizing their detection methods, Ursa Analytics seeks to enhance antimicrobial treatment efficacy in hospitals worldwide, ultimately improving patient outcomes and reducing healthcare costs associated with sepsis.

Generated from the website